S
T
O
C
K
n
e
w
s
r
o
o
m
.
C
O
M
Stocks
Regions
Markets
Commodities
Indices & Futures
Forex
Crypto
Economy & Politics
Central Banks
Bonds & Rates
Community
S&P 500
7,585
+0.03%
DJIA
51,042
+0.57%
Nasdaq
30,350
+0.23%
DAX
25,052
-0.22%
Gold
$4,196
+0.16%
Oil
$87.81
-0.77%
BTC
$73,629
+0.08%
VIX
17.63
-1.26%
EUR/USD
1.1785
-0.02%
ETH
$2,017
+0.19%
S&P 500
7,585
+0.03%
DJIA
51,042
+0.57%
Nasdaq
30,350
+0.23%
DAX
25,052
-0.22%
Gold
$4,196
+0.16%
Oil
$87.81
-0.77%
BTC
$73,629
+0.08%
VIX
17.63
-1.26%
EUR/USD
1.1785
-0.02%
ETH
$2,017
+0.19%
Stocks
Regions
Markets
Commodities
Indices & Futures
Forex
Crypto
Economy & Politics
Central Banks
Bonds & Rates
Community
Sector
Healthcare
35 articles
NVO
Novo Nordisk Wegovy Strategy +2.9% Rally After 70% Slide
Mar 31, 2026 · Mar 31, 2026
ABBV
AbbVie Dermatology Data Boom at AAD 2026 Shocks Investors
Mar 27, 2026 · Mar 27, 2026
HIMS
Hims & Hers GLP-1 partnership sparks new weight-loss boom
Mar 26, 2026 · Mar 26, 2026
MRK.DE
Merck Terns Acquisition $6.7B Surge as Keytruda Cliff Nears
Mar 25, 2026 · Mar 25, 2026
LLY
Eli Lilly GLP-1 Strategy Boom and Revenue Shock
Mar 24, 2026 · Mar 24, 2026
PFE
Pfizer Lyme vaccine 70% efficacy Shock as PFE slips
Mar 23, 2026 · Mar 23, 2026
LLY
Eli Lilly Retatrutide Boom: Triple-Agonist Trial Shock
Mar 19, 2026 · Mar 19, 2026
LLY
Eli Lilly Forecast Warning after HSBC’s bearish reset
Mar 18, 2026 · Mar 18, 2026
JNJ
Johnson & Johnson FDA approval ICOTYDE Boom Explained
Mar 18, 2026 · Mar 18, 2026
HIMS
Hims & Hers insider transactions Warning as GLP-1 bets grow
Mar 17, 2026 · Mar 17, 2026
Posts pagination
Previous
1
2
3
4
Next
